Megaloblastic Anaemia: Causes, Symptoms and Treatment

Fatigue builds over months, blood tests show low haemoglobin, yet iron supplements make no difference. Then comes tingling in the fingers, unsteadiness on your feet, a strange numbness spreading up the legs. This is how megaloblastic anaemia often begins — a condition in which blood cells become abnormally large and lose the ability to function normally.

What Is Megaloblastic Anaemia and How Does It Develop

Megaloblastic anaemia is anaemia caused by impaired DNA synthesis in blood cell precursors in the bone marrow. The main culprits are vitamin B12 deficiency and folate deficiency: both nutrients are required for normal cell division.

When DNA synthesis is disrupted, red cell precursors keep growing and accumulating haemoglobin, but cannot divide. Imagine a factory where workers keep assembling components but the production line never moves — output builds up yet nothing reaches the end-user. The result is a bone marrow full of abnormally large, immature cells called megaloblasts. The red cells that do make it into the bloodstream are also oversized (macrocytes) and live a shorter-than-normal lifespan.

The same disruption affects all rapidly dividing cells — white cells and platelets — so in severe megaloblastic anaemia, all three cell lines may fall.

Two distinct scenarios matter clinically:

• Vitamin B12 deficiency → anaemia + potential irreversible neurological damage if untreated
• Folate deficiency → anaemia only, without neurological involvement

This distinction is critical: treating B12 deficiency with folate alone will mask the anaemia while neurological damage continues to progress undetected.

Symptoms of Megaloblastic Anaemia

Megaloblastic anaemia develops slowly — liver stores of B12 last 3–5 years, whereas folate reserves last only 3–4 months. B12 deficiency therefore creeps up unnoticed, and its symptoms are often attributed to overwork or normal ageing.

General anaemia symptoms:

• pronounced weakness and rapid fatigue;
• breathlessness on exertion that was not present before;
• pallor with a slight yellowish tinge — caused by simultaneous breakdown of oversized red cells;
• palpitations.

Neurological signs (B12 deficiency):

• tingling and numbness in hands and feet — the "gloves and socks" distribution;
• unsteady gait, difficulty walking in the dark (proprioception loss);
• muscle spasticity, leg weakness;
• cognitive impairment: memory decline, poor concentration, irritability;
• depression, occasionally psychosis — particularly in elderly patients.

Oral and gastrointestinal signs:

• glossitis — a smooth, painful, bright red tongue (Hunter's glossitis);
• burning tongue sensation;
• poor appetite, nausea.

The yellowish skin tint in megaloblastic anaemia reflects intramedullary destruction of megaloblasts and the shortened lifespan of macrocytes — this is so-called ineffective erythropoiesis with an element of haemolytic anaemia. The word "anaemia" here does not simply mean "too little blood" — it describes a complex pathological process with multiple simultaneous mechanisms.

Megaloblastic Anaemia Blood Test Findings

The laboratory picture is characteristic enough to point toward the diagnosis even before specific tests are ordered.

Parameter	Change	Mechanism
Haemoglobin	↓	Insufficient red cell production
MCV	↑ markedly	Megalocytes and macrocytes instead of normal-sized cells
Reticulocytes	↓	Ineffective erythropoiesis — few mature cells reach the bloodstream
LDH	↑ markedly	Intramedullary destruction of megaloblasts
Bilirubin	↑ (unconjugated)	Haemolysis of short-lived macrocytes
White blood cells	↓ (severe cases)	Impaired precursor division
Platelets	↓ (severe cases)	Same mechanism

A characteristic microscopic finding is hypersegmented neutrophils (five or more nuclear lobes in ≥5% of neutrophils). This is an early and specific sign of megaloblastosis that can appear even before haemoglobin falls.

A markedly elevated LDH alongside macrocytic anaemia is practically a diagnostic combination that points directly to megaloblastic anaemia rather than other causes of macrocytosis.

Causes: Pernicious Anaemia, B12 Deficiency and Folate Deficiency

Vitamin B12 deficiency arises through one of several pathways:

• Pernicious anaemia (autoimmune gastritis type A) — the most common cause of B12 deficiency in adults. The immune system attacks the gastric cells that produce intrinsic factor — the protein without which B12 cannot be absorbed in the ileum. Pernicious anaemia is autoimmune and often co-exists with other autoimmune diseases.
• Strict veganism — the only reliable B12 sources are animal products. Without supplements, deficiency typically develops after 3–5 years.
• Gastric surgery (gastrectomy, bariatric procedures) — removing part of the stomach reduces intrinsic factor production.
• Crohn's disease, celiac disease — inflammation or atrophy in the ileum impairs B12 absorption.
• Long-term metformin use — blocks calcium-dependent intestinal B12 absorption; B12 levels should be checked annually after more than 3 years of use.

Folate deficiency develops much faster (reserves last 3–4 months) and is more commonly caused by:

• Poor diet — especially in elderly patients and people who consume excessive alcohol (alcohol blocks folate absorption);
• Pregnancy — folate requirements increase sharply for rapid DNA synthesis in the developing foetus;
• Malabsorption — celiac disease, inflammatory bowel disease;
• Medications — methotrexate, trimethoprim, some anticonvulsants.

Diagnosing Macrocytic Anaemia: Which Tests Are Ordered

When macrocytic anaemia or characteristic neurological symptoms are present, the following workup is performed:

• Vitamin B12 level — the primary test. Below 150 pmol/L is clear deficiency; 150–220 pmol/L is a grey zone where clinically significant deficiency is possible despite a borderline result.
• Serum folate — below 7 nmol/L indicates deficiency. Serum folate reflects recent dietary intake (last few weeks); red cell folate is measured when a longer-term status marker is needed.
• Complete blood count with morphology — essential: identifies MCV elevation, anaemia severity, and hypersegmented neutrophils.
• Methylmalonic acid (MMA) — rises with B12 deficiency before the serum B12 level falls, making it an extremely sensitive early marker. Invaluable at borderline B12 values.
• Intrinsic factor antibodies and anti-parietal cell antibodies — confirm pernicious anaemia as the cause.
• Homocysteine — elevated in both B12 and folate deficiency (unlike MMA, which is specific to B12 alone).

Treatment of Megaloblastic Anaemia

Treatment depends on whether B12, folate, or both are deficient.

For vitamin B12 deficiency:

• Intramuscular cyanocobalamin injections — standard of care for pernicious anaemia and any malabsorption. Daily injections for 1–2 weeks, then monthly maintenance injections lifelong.
• High-dose oral B12 (1000–2000 µg/day) — proven effective even in pernicious anaemia, because a small fraction of B12 is absorbed by passive diffusion without intrinsic factor. Suitable for patients without severe neurological involvement.

The response to B12 treatment is rapid: within 3–5 days a reticulocyte surge occurs — a sign that the bone marrow has reactivated. Haemoglobin normalises over 6–8 weeks. Neurological symptoms recover much more slowly — months to a year; long-established changes may be permanent.

For folate deficiency:

• Oral folic acid 1–5 mg/day for 4 months or until the underlying cause is corrected.

A critical warning: never start folic acid empirically in macrocytic anaemia before ruling out B12 deficiency. Folate will correct the anaemia but cannot halt the neurological damage from B12 deficiency — and the subjective sense of improvement will mislead both patient and doctor. This is a classic and dangerous trap.

When pernicious anaemia is confirmed, long-term monitoring includes periodic gastroscopy due to an elevated risk of gastric cancer. For a detailed review of B12 sources and symptoms, see the article on vitamin B12 deficiency.

When to Seek Urgent Care

Seek medical attention promptly if any of the following appear alongside anaemia:

• rapidly worsening leg weakness or difficulty walking;
• spreading numbness and tingling in the limbs;
• balance problems or unsteadiness in the dark;
• confusion or disorientation — especially in elderly patients;
• breathlessness at rest or palpitations with minimal activity.

Megaloblastic anaemia responds well to treatment when caught early. Neurological complications from prolonged B12 deficiency can be irreversible — which is why delaying diagnosis carries real risk. Do not interpret blood test results on your own; consult a doctor.